Mycronic AB (publ) (STO:MYCR)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 57.21B |
| Revenue (ttm) | 8.30B |
| Net Income (ttm) | 1.66B |
| Shares Out | 195.27M |
| EPS (ttm) | 8.47 |
| PE Ratio | 34.59 |
| Forward PE | 34.65 |
| Dividend | 3.25 (1.11%) |
| Ex-Dividend Date | May 7, 2026 |
| Volume | 301,901 |
| Average Volume | 279,747 |
| Open | 290.00 |
| Previous Close | 293.00 |
| Day's Range | 285.40 - 291.20 |
| 52-Week Range | 174.00 - 303.60 |
| Beta | 0.61 |
| RSI | 76.77 |
| Earnings Date | Apr 1, 2026 |
About Mycronic AB
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors. The PCB Assembly segment develops, manufactures, and markets flex... [Read more]
Financial Performance
In 2025, Mycronic AB's revenue was 7.94 billion, an increase of 12.48% compared to the previous year's 7.06 billion. Earnings were 1.56 billion, a decrease of -7.31%.
Financial StatementsNews
Mycronic AB Earnings Call Transcript: Q1 2026
Q1 delivered record sales and EBIT, driven by strong demand in High Volume and Global Technologies, leading to an upgraded 2026 sales outlook. Pattern Generators saw robust sales but lower order intake, while PCB Assembly Solutions remained weak. AI and OLED trends continue to support growth.
Mycronic AB (FRA:MLT0) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Mycronic AB (FRA:MLT0) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth and Dividend Boost
Q4 2025 Mycronic AB (publ) Earnings Call Transcript
Q4 2025 Mycronic AB (publ) Earnings Call Transcript
Mycronic AB Earnings Call Transcript: Q4 2025
Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with continued R&D investment and a positive outlook for Global Technologies and High Volume divisions.
Mycronic Wins Up To $16 Mln Prexision 8 Evo Order, Delivery Slated For Q1 2027
(RTTNews) - Mycronic AB (publ) announced that it has received a replacement order for a Prexision 8 Evo from an existing customer in Asia. The order is valued in the range of US$14 million - US$16 mil...
Q2 2025 Mycronic AB (publ) Earnings Call Transcript
Q2 2025 Mycronic AB (publ) Earnings Call Transcript
Mycronic AB (FRA:MLT0) Q3 2025 Earnings Call Highlights: Strong Order Intake Amid Sales Decline
Mycronic AB (FRA:MLT0) Q3 2025 Earnings Call Highlights: Strong Order Intake Amid Sales Decline
Q3 2025 Mycronic AB (publ) Earnings Call Transcript
Q3 2025 Mycronic AB (publ) Earnings Call Transcript
Mycronic AB Earnings Call Transcript: Q3 2025
Order intake surged 67% year-over-year, led by Pattern Generators and Global Technologies, while sales dipped 4% and EBIT margin fell to 15% due to product mix. Backlog and cash remain strong, with continued M&A activity and a positive full-year outlook.
Mycronic AB Earnings Call Transcript: Q2 2025
Q2 saw 35% sales growth and a 27% EBIT margin, with strong performance in Pattern Generators and High Volume, but order intake declined due to no new system orders. Three acquisitions and a share split were completed, and full-year sales guidance was reaffirmed at SEK 7.5 billion.
Mycronic AB (STU:MLT) Q1 2025 Earnings Call Highlights: Record EBIT and Strategic Acquisitions ...
Mycronic AB (STU:MLT) Q1 2025 Earnings Call Highlights: Record EBIT and Strategic Acquisitions Drive Growth Amid Market Uncertainty
Q1 2025 Mycronic AB (publ) Earnings Call Transcript
Q1 2025 Mycronic AB (publ) Earnings Call Transcript
Mycronic AB Earnings Call Transcript: Q1 2025
Q1 delivered record sales and EBIT, driven by strong Pattern Generators and High Volume performance, while High Flex lagged. Guidance was revised to SEK 7–7.5 billion due to tariff and currency uncertainty, with new acquisitions and expansion in Southeast Asia supporting future growth.
Mycronic AB Earnings Call Transcript: Q4 2024
Record Q4 and full-year results with strong sales, order intake, and EBIT margin. All divisions exceeded margin targets, and significant investments in R&D and sales network are planned for 2025. Dividend increased, with continued focus on both organic growth and M&A.
Mycronic AB Earnings Call Transcript: Q3 2024
Sales rose 40% year-over-year to SEK 1.8 billion, led by Pattern Generators, with EBIT margin at 31%. High Flex remains weak in Europe, while High Volume and Global Technologies saw strong growth. Full-year sales target of SEK 6.5 billion reaffirmed.
Mycronic AB Earnings Call Transcript: Q2 2024
Q2 delivered strong sales and order growth, with EBIT doubling and a raised full-year sales outlook. Pattern Generators led performance, while High Flex and High Volume showed improvement. New sustainability targets and the Vanguard acquisition marked key strategic steps.